CG
AMED

Carmignac Gestion’s Amedisys AMED Stock Holding History

Carmignac Gestion’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,725
Closed -$3.21M – 144
2023
Q4 		$3.21M Hold
33,725
– – 0.05% 89
2023
Q3 		$3.15M Buy
33,725
+26,598
+373% +$2.46M 0.06% 82
2023
Q2 		$652K Buy
+7,127
New +$585K 0.01% 135
2022
Q1 		– Sell
-155,347
Closed -$25.1M – 114
2021
Q4 		$25.1M Sell
155,347
-121,988
-44% -$19.6M 0.35% 43
2021
Q3 		$41.4M Buy
277,335
+67,531
+32% +$14M 0.52% 43
2021
Q2 		$51.4M Buy
209,804
+1,900
+0.9% +$499K 0.6% 43
2021
Q1 		$55.1M Buy
207,904
+97,292
+88% +$27.4M 0.63% 43
2020
Q4 		$32.4M Sell
110,612
-56,696
-34% -$14.5M 0.34% 52
2020
Q3 		$39.6M Sell
167,308
-1,000
-0.6% -$227K 0.47% 47
2020
Q2 		$33.4M Buy
+168,308
New +$31.4M 0.46% 45

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Carmignac Gestion's AMED Position: Q1 2024 in Review

Carmignac Gestion sold out of Amedisys (AMED) in Q1 2024, closing a stake of 33,725 shares — an estimated $3.21M sold.

Carmignac Gestion first reported a position in AMED in Q2 2020 and held it in 10 quarters. The position peaked at $55.1M in Q1 2021. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Carmignac Gestion reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Carmignac Gestion sold 33,725 Amedisys shares in Q1 2024, an estimated $3.21M.
  • Carmignac Gestion first reported a position in Amedisys in Q2 2020 and held it in 10 quarters.
  • Carmignac Gestion's Amedisys position peaked at $55.1M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.